Stay updated on Nivolumab Combo in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Head and Neck Cancer Clinical Trial page
- Check6 days agoChange DetectedLocations section added listing US states and Japanese prefectures (Aichi-ken, Chiba, Ehime, Fukuoka, Hyōgo, Ibaraki, Kanagawa, Miyagi, Osaka, Tokyo); Revision: v3.3.3.SummaryDifference2%

- Check13 days agoChange DetectedAdded the disease focus term Head and neck squamous cell carcinoma and a related topic link to MedlinePlus Genetics.SummaryDifference0.1%

- Check14 days agoChange DetectedDeleted related topic labels 'Head and neck squamous cell carcinoma' and 'MedlinePlus Genetics' from the Related Topics section. This peripheral UI change does not affect the study content, eligibility, or results.SummaryDifference0.1%

- Check23 days agoChange DetectedHead and neck squamous cell carcinoma was added as a topic, and MedlinePlus Genetics is listed as a related topic. The revision note shows Revision: v3.3.2, replacing v3.3.1.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1, a technical version change with no impact on the study information or how the page is used. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange Detected- Added a new study site: Tainan, Taiwan, 704.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combo in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head and Neck Cancer Clinical Trial page.